Jci_page_head_homepage_01 Jci_page_head_homepage_02
Craig Brooks, Qingqing Wei, Sung-Gyu Cho, Zheng Dong
Published in Volume 119, Issue 5
J Clin Invest. 2009; 119(5):1275–1285 doi:10.1172/JCI37829
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Inhibition of ATP depletion–induced apoptosis by DN-Drp1.

(A) Effects of DN-Drp1 on azide-induced apoptosis. RPTCs were cotransfected with GFP and DN-Drp1 or empty vector. Cells were then treated with 10 mM azide for 3 hours followed by 2 hours recovery. After treatment, cells were subjected to TUNEL assay. Cells were examined by fluorescence microscopy to determine the percentage of apoptosis (TUNEL positive) in transfected (GFP labeled) cells. (B) Representative cell morphology. RPTCs were transfected with wild-type or DN-Drp1 and then subjected to 3 hours of azide treatment followed by 2 hours recovery. Cells were stained with Hoechst 33342 and examined by fluorescence microscopy. Scale bars: 5 μm. (C) Effects of DN-Drp1 on cisplatin-induced apoptosis. RPTCs were cotransfected with GFP and DN-Drp1 or empty vector and then incubated with 20 μM cisplatin for 16 hours. Cells were stained with Hoechst 33342 for examination by fluorescence microscopy to determine the percentage of apoptosis in transfected (GFP labeled) cells. Data in A and C are presented as mean ± SD; n ≥ 3. *P < 0.05, significantly different from untreated control; #P < 0.05, significantly different from vector-transfected cells treated with azide or cisplatin.